1. Home
  2. ALDX vs ESEA Comparison

ALDX vs ESEA Comparison

Compare ALDX & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • ESEA
  • Stock Information
  • Founded
  • ALDX 2004
  • ESEA 2005
  • Country
  • ALDX United States
  • ESEA Greece
  • Employees
  • ALDX N/A
  • ESEA N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • ESEA Marine Transportation
  • Sector
  • ALDX Health Care
  • ESEA Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • ESEA Nasdaq
  • Market Cap
  • ALDX 319.4M
  • ESEA 293.8M
  • IPO Year
  • ALDX 2014
  • ESEA 2006
  • Fundamental
  • Price
  • ALDX $5.02
  • ESEA $35.30
  • Analyst Decision
  • ALDX Strong Buy
  • ESEA Buy
  • Analyst Count
  • ALDX 2
  • ESEA 1
  • Target Price
  • ALDX $10.00
  • ESEA $53.00
  • AVG Volume (30 Days)
  • ALDX 380.6K
  • ESEA 48.8K
  • Earning Date
  • ALDX 11-07-2024
  • ESEA 02-19-2025
  • Dividend Yield
  • ALDX N/A
  • ESEA 6.85%
  • EPS Growth
  • ALDX N/A
  • ESEA 3.12
  • EPS
  • ALDX N/A
  • ESEA 16.28
  • Revenue
  • ALDX N/A
  • ESEA $208,648,067.00
  • Revenue This Year
  • ALDX N/A
  • ESEA $13.85
  • Revenue Next Year
  • ALDX N/A
  • ESEA $6.69
  • P/E Ratio
  • ALDX N/A
  • ESEA $2.18
  • Revenue Growth
  • ALDX N/A
  • ESEA 13.90
  • 52 Week Low
  • ALDX $2.71
  • ESEA $30.78
  • 52 Week High
  • ALDX $6.55
  • ESEA $50.92
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 50.69
  • ESEA 39.87
  • Support Level
  • ALDX $4.67
  • ESEA $32.93
  • Resistance Level
  • ALDX $5.45
  • ESEA $36.00
  • Average True Range (ATR)
  • ALDX 0.33
  • ESEA 1.41
  • MACD
  • ALDX -0.01
  • ESEA 0.04
  • Stochastic Oscillator
  • ALDX 44.30
  • ESEA 31.60

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

Share on Social Networks: